Could a smart pen take the guesswork out of insulin dosing?

NCT ID NCT06406439

Completed Disease control Sponsor: G2e Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This trial tests whether a smart insulin pen called DIA:CONN P8 can help people with type 1, type 2, or pancreatogenic diabetes better control their blood sugar. Participants use the pen for 12 weeks, and the pen automatically calculates bolus insulin doses based on meal information and other factors. The study compares changes in HbA1c levels between those using the smart pen and those using standard insulin injections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a smart insulin pen called DIA:CONN P8 that automatically calculates and sets bolus insulin doses based on meal information and other indicators
What this could lead to: If it works, this could make daily insulin management easier and more accurate, potentially improving blood sugar control and reducing the mental burden of dose calculations.
What could go wrong: This is a relatively small, early-stage trial, and the device may not prove superior to standard insulin pens. Technical failures or user errors could also limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES (INSULIN-REQUIRING, TYPE 1 OR TYPE 2) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES (INSULIN-REQUIRING, TYPE 1 OR TYPE 2) PANCREATOGENIC DIABETES MELLITUS

Contacts and locations

Locations

Chung-Ang University Gwangmyeong Hospital

Gwangmyeong, Deokan-ro, 14353, South Korea
Kangbuk Samsung Hospital

Seoul, Jongno-gu, 03181, South Korea
Kyung Hee University Hospital

Seoul, Dongdaemun-gu, 02447, South Korea
Kyung Hee University Hospital at Gangdong

Seoul, Gangdong-gu, 05278, South Korea
National Health Insurance Service Ilsan Hospital

Goyang-si, Ilsandong-gu, 10444, South Korea
Samsung Changwon Hospital

Changwon, Masanhoewon-gu, 51353, South Korea
Samsung Medical Center

Seoul, Gangnam-gu, 06351, South Korea
Seoul St. Mary's Hospital

Seoul, Seocho-gu, 06591, South Korea
Severance Hospital

Seoul, Seodaemun-gu, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.